Published • loading... • Updated
Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher
Summary by 24/7 Wall St.
1 Articles
1 Articles
Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher
Merck and Eli Lilly both beat Wall Street, but their paths to profit look nothing alike, and the gap between them could widen sharply as one faces a looming patent cliff and the other rides an unstoppable drug category.
·Lakewood, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
